Iridex (IRIX) Non-Current Deffered Revenue (2018 - 2026)
Iridex (IRIX) recorded quarterly Non-Current Deffered Revenue of $6.4 million in Q2 2026, down 5.57% quarter-over-quarter from $6.8 million in Q1 2026, and down 19.4% on a YoY basis from $8.0 million in Q2 2025.
Iridex (IRIX) Non-Current Deffered Revenue (2018 - 2026) Analysis & Trends
Iridex's Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $6.4 million for Q2 2026.
- In Q2 2026, Non-Current Deffered Revenue fell 19.4% year-over-year to $6.4 million; the TTM figure through Apr 2026 stood at $6.4 million (down 19.4% YoY), while the FY2026 annual figure was $6.8 million, down 18.55% from the prior year.
- Non-Current Deffered Revenue was $6.4 million for Q2 2026 at Iridex, down from $6.8 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $12.5 million in Q3 2022 to a low of $6.4 million in Q2 2026.
- Historically, Non-Current Deffered Revenue has averaged $9.7 million across 5 years, with a median of $9.9 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Non-Current Deffered Revenue jumped 3682.01% in 2022, then retreated 19.4% in 2026.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $11.7 million in 2022, then slipped by 14.62% to $10.0 million in 2023, then fell by 16.71% to $8.4 million in 2024, then slipped by 13.68% to $7.2 million in 2025, then fell by 10.9% to $6.4 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $6.4 million (Q2 2026), $6.8 million (Q1 2026), and $7.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Iridex | 19.91 Mn | 15.31 Mn | 4.74 Mn | 6.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 6.42 Mn |
| Jan 3, 2026 | 6.80 Mn |
| Sep 27, 2025 | 7.21 Mn |
| Jun 28, 2025 | 7.59 Mn |
| Mar 29, 2025 | 7.97 Mn |
| Dec 28, 2024 | 8.35 Mn |
| Sep 28, 2024 | 8.76 Mn |
| Jun 29, 2024 | 9.26 Mn |
| Mar 30, 2024 | 9.71 Mn |
| Dec 30, 2023 | 10.03 Mn |
| Sep 30, 2023 | 10.47 Mn |
| Jul 1, 2023 | 10.88 Mn |
| Apr 1, 2023 | 11.31 Mn |
| Dec 31, 2022 | 11.74 Mn |
| Oct 1, 2022 | 12.17 Mn |
| Jul 2, 2022 | 12.54 Mn |
| Apr 2, 2022 | 12.53 Mn |
| Jan 1, 2022 | 10.93 Mn |
| Oct 2, 2021 | 10.20 Mn |
| Jul 3, 2021 | 10.48 Mn |